IVERIC bio, Inc. Soared

IVERIC bio, Inc. (ISEE:NASDAQ) shot up at $14.12, representing a gain of 62.5%. On Thu, Sep 09, 2021, ISEE:NASDAQ touched a New 2-Week Low of $8.69. The stock got featured on our News Catalysts scanner on Fri, Sep 10, 2021 at 04:50 PM in the 'MISCELLANEOUS' category. From Thu, Aug 26, 2021, the stock recorded 22.22% Up Days and 30.00% Green Days

About IVERIC bio, Inc. (ISEE:NASDAQ)

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate, Fovista, an anti-platelet-derived growth factor, is in Phase III clinical development for use in combination with anti-vascular endothelial growth factor drugs for the treatment of wet age-related macular degeneration (AMD). The company is also engaged in developing Zimura, an inhibitor of complement factor C5, for the treatment of dry AMD and wet AMD. All the business activity of the group is functioned through the United States.